Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Resverlogix Corp
T.RVX
Alternate Symbol(s):
RVXCF
Healthcare
Biotechnology
Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the...
treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:RVX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(4)
•••
QualityTest
X
View Profile
View Bullboard History
Post by
QualityTest
on Feb 15, 2022 8:25am
First Patient Dosed - Jan 18
Given that patients are dosed for 28 days, we're coming up to the point in time where RVX will be able to see the full effects after patients have completed the trial. By the time we hear from DM
...more
(16)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Feb 14, 2022 10:19am
RE:Silence
QT,,,this is on the QT,,,,, you dont want pinocchio to open his pie hole or we will certainly get wholloped,,,its part of the history around this compnay,,,what they think it supportive news actually
...more
(4)
•••
QualityTest
X
View Profile
View Bullboard History
Post by
QualityTest
on Feb 14, 2022 8:37am
Silence
Shite. I thought we were going to get an announcement of a CC this week this morn. DM keeping his mouth shut for this long isn't a good sign. Down we go today.
(16)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Feb 12, 2022 5:22pm
RE:RE:Our blockbuster,,,,,
,,,where would apabetalone stnad in Canada,, even if the 100 patient trial is successful,,,,,possibly in the bleachers,,,,,, I think the Governement has signed contracts with Pfizer out for the next
...more
(27)
•••
Jkj193741
X
View Profile
View Bullboard History
Comment by
Jkj193741
on Feb 10, 2022 1:38pm
RE:Our blockbuster,,,,,
FOR SURE! AMEN AND AMEN! Jk
(16)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Feb 10, 2022 1:05pm
RE:Our blockbuster,,,,,
,,,I read where Koo has posted the short numbers on the other board. Seems it has increased since the good news of dosing,,,RVX has over 1.2 million shares out on the short side,,,,,,that could be
...more
(16)
•••
narmac
X
View Profile
View Bullboard History
Post by
narmac
on Feb 10, 2022 12:06pm
Our blockbuster,,,,,
,,continues to be a ballbuster,,,,,,,,the lack of interest haunts this company ,,,,cuz no one out there believes Pinocchio,,,,,nor should they,,,,,,,we need Kulikowski,,,or Sweeney,,,,,,or Wong
...more
(16)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Feb 08, 2022 2:27pm
RE:Molnupiravir Sales
aacchhhh,,,,,,it would be awesome,,but chances are,, they will mumble and fumble and bumble the trial,,,,,,then scratch their nut sacks, (except for Ewelina),,,and tell us the trial was not designed
...more
(4)
•••
QualityTest
X
View Profile
View Bullboard History
Post by
QualityTest
on Feb 08, 2022 12:22pm
Molnupiravir Sales
Merck is estimating sales of 5-6 billion this year from their not-that-great drug. Pfizer is estimating sales of 22 billion for paxlovid. Would be nice if RVX could show ANY signs of this trial
...more
(0)
•••
elviradyer208
X
View Profile
View Bullboard History
Post by
elviradyer208
on Feb 08, 2022 12:54am
India will soon provide 5G fast internet network
The Indian government is targeting the auction of 5G mobile internet network spectrum to begin in March. With this, the internet network will be activated immediately to serve the Hindustan
...more
(0)
•••
elviradyer208
X
View Profile
View Bullboard History
Post by
elviradyer208
on Feb 04, 2022 5:24pm
The Irony of Cervical Cancer Amid Vaccine and Screening Adva
In commemoration of World Cancer Day today, the entire community is again reminded of the dangers of cancer, including cervical cancer. Globocan data in 2020 showed that there were
...more
(24)
•••
Storm23
X
View Profile
View Bullboard History
Post by
Storm23
on Feb 03, 2022 2:27pm
rvx on global news
today at noon, def getting the word out.Now we need the drug to work on covid and it's kaboom!
(0)
•••
elviradyer208
X
View Profile
View Bullboard History
Post by
elviradyer208
on Feb 03, 2022 12:59pm
Exxon Makes Biggest Profit in 7 Years as Oil Prices Rise
Exxon Mobil Corp, the oil and gas giant from the United States, reported a profit of US$ 8.87 billion or around Rp. 126.8 trillion in the fourth quarter of 2021. This achievement was the
...more
(16)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Feb 03, 2022 7:59am
RE:RE:Sweeney & McCaffrey yesterday on CBC Radio!
Hi,,,GV,,,I have never lost interest in the science,,,,which most other investors hold onto as well. I am sick and tired off the ineptness within the management team around accompilishing anything
...more
(107)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Feb 02, 2022 3:00pm
RE:Sweeney & McCaffrey yesterday on CBC Radio!
Hello narmac. It seems your interest in RVX is coming back slowly. On the issue you raised on the "Long Covid", according to Dr. Sweeney in the CBC interview... "most of the
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Debt-Free Cannabis Company Set for Next Stage of Growth
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
Learn How this Company is Disrupting Point-of-Care Testing
Why Dozens of Pro Athletes are Paying Attention to this Product
Do you want to stay ahead of the markets? See how DealRoom can help.